Literature DB >> 19009271

Isolation of JFH-1 strain and development of an HCV infection system.

Takaji Wakita1.   

Abstract

Detailed analysis of hepatitis C virus (HCV) has been hampered by the lack of an appropriate viral culture system and small animal models of infection. My group and others have recently reported the production of infectious virus after full-length HCV RNA transfection into Huh-7 cells. This system depends primarily on isolation of a JFH-1 strain from a patient with fulminant hepatitis. The JFH-1 strain belongs to genotype 2a and has high colony-formation efficiency when tested with a subgenomic replicon system. Here, I describe various protocols for isolation of the JFH-1 strain and construction of the HCV infection system. The HCV infection system contributes to our understanding of HCV virology and may permit development of novel antiviral strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19009271     DOI: 10.1007/978-1-59745-394-3_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.

Authors:  Tomoko Date; Takanobu Kato; Junko Kato; Hitoshi Takahashi; Kenichi Morikawa; Daisuke Akazawa; Asako Murayama; Keiko Tanaka-Kaneko; Tetsutaro Sata; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Enhanced protocol for determining the 3' terminus of hepatitis C virus.

Authors:  Xiaoan Zhang; Xiaofeng Fan; Yanjuan Xu; Adrian M Di Bisceglie
Journal:  J Virol Methods       Date:  2010-04-08       Impact factor: 2.014

3.  Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.

Authors:  Ying Zhang; Cheng J Ma; Jia M Wang; Xiao J Ji; Xiao Y Wu; Zhan S Jia; Jonathan P Moorman; Zhi Q Yao
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

4.  Viral Load Analysis of Hepatitis C Virus in Huh7.5 Cell Culture System.

Authors:  Roghayeh Teimourpour; Zahra Meshkat; Aida Gholoubi; Hosein Nomani; Sina Rostami
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

5.  Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure.

Authors:  Takeshi Hatanaka; Atsushi Naganuma; Yumeo Tateyama; Fukiko Yoshinari; Takashi Hoshino; Ken Sato; Su Su Hmwe; Hideki Aizaki; Takaji Wakita; Satoru Kakizaki; Toshio Uraoka
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

6.  Reticulon-3 modulates the incorporation of replication competent hepatitis C virus molecules for release inside infectious exosomes.

Authors:  Jingjing Li; Ebtisam Abosmaha; Carla S Coffin; Patrick Labonté; Terence Ndonyi Bukong
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

Review 7.  Bile Goes Viral.

Authors:  Victoria R Tenge; Kosuke Murakami; Wilhelm Salmen; Shih-Ching Lin; Sue E Crawford; Frederick H Neill; B V Venkataram Prasad; Robert L Atmar; Mary K Estes
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

8.  Rab18 binds to hepatitis C virus NS5A and promotes interaction between sites of viral replication and lipid droplets.

Authors:  Shadi Salloum; Hongliang Wang; Charles Ferguson; Robert G Parton; Andrew W Tai
Journal:  PLoS Pathog       Date:  2013-08-01       Impact factor: 6.823

9.  Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5.

Authors:  Weifeng Gong; Xiaobo Guo; Yangmin Zhang
Journal:  Yonsei Med J       Date:  2018-12       Impact factor: 2.759

10.  Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway.

Authors:  Kazuhiro Murai; Hayato Hikita; Yugo Kai; Yasuteru Kondo; Makoto Fukuoka; Keisuke Fukutomi; Akira Doi; Takuo Yamai; Tasuku Nakabori; Ryo Fukuda; Takeshi Takahashi; Kei Miyakawa; Hiroshi Suemizu; Akihide Ryo; Ryoko Yamada; Takahiro Kodama; Ryotaro Sakamori; Tomohide Tatsumi; Tetsuo Takehara
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.